Pregnancy Prevention — Comparative Study of the Contraceptive Efficacy of the Cupid, Cupid 2 and FC2 Female Condom
Citation(s)
Beksinska M, Greener R, Kleinschmidt I, Pillay L, Maphumulo V, Smit J A randomized noninferiority crossover controlled trial of the functional performance and safety of new female condoms: an evaluation of the Velvet, Cupid2, and FC2. Contraception. 2015 Sep;92(3):261-7. doi: 10.1016/j.contraception.2015.05.008. Epub 2015 May 20.
Beksinska M, Smit J, Joanis C, Potter W New female condoms in the pipeline. Reprod Health Matters. 2012 Dec;20(40):188-96. doi: 10.1016/S0968-8080(12)40659-0.
Beksinska ME, Piaggio G, Smit JA, Wu J, Zhang Y, Pienaar J, Greener R, Zhou Y, Joanis C Performance and safety of the second-generation female condom (FC2) versus the Woman's, the VA worn-of-women, and the Cupid female condoms: a randomised controlled non-inferiority crossover trial. Lancet Glob Health. 2013 Sep;1(3):e146-52. doi: 10.1016/S2214-109X(13)70054-8. Epub 2013 Aug 23.
Bounds W, Guillebaud J, Newman G B Female Condom (Femidom). A clinical study of its use-effectiveness and patient acceptability. The British Journal of Family Planning 1992; 18:3641.
Center for Health and Gender Equity Female condoms and US foreign assistance: an unfinished imperative for women's health. Washington, DC; 2011. https://www.unfpaprocurement.org/documents/10157/37547/UNFPA+Female+Cond om+Prequalification+List/05feba45-4893-474a-81d4-7b61e4f68ae7
Farley TM Life-table methods for contraceptive research. Stat Med. 1986 Sep-Oct;5(5):475-89.
Mantell JE, Scheepers E, Karim QA Introducing the female condom through the public health sector: experiences from South Africa. AIDS Care. 2000 Oct;12(5):589-601.
Peters A, Jansen W, van Driel F The female condom: the international denial of a strong potential. Reprod Health Matters. 2010 May;18(35):119-28. doi: 10.1016/S0968-8080(10)35499-1.
Reproductive Health Supplies Coalition Caucus on new and underused reproductive health technologies. Product brief: female condom. Reproductive Health Supplies Coalition; 2013. [Online]. [Cited: 19th Dec 2016]. URL: https://www.rhsupplies.org/fileadmin/uploads/rhsc/Working_Groups/New_Underused_RH_Technologies_Caucus/Documents/Technical_Briefs/rhsc-brief-female-condom_A4.pdf
Trussel J Contraceptive efficacy of the Reality female condom. Contraception 1998;58: 148.
Trussell J, Sturgen K, Strickler J, Dominik R Comparative contraceptive efficacy of the female condom and other barrier methods. Fam Plann Perspect. 1994 Mar-Apr;26(2):66-72. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
